1160 related articles for article (PubMed ID: 26429802)
21. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
Parveen S; Singh SP; Panicker MM; Gupta PK
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
[TBL] [Abstract][Full Text] [Related]
22. Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories.
Hwang HS; Kryshtal DO; Feaster TK; Sánchez-Freire V; Zhang J; Kamp TJ; Hong CC; Wu JC; Knollmann BC
J Mol Cell Cardiol; 2015 Aug; 85():79-88. PubMed ID: 25982839
[TBL] [Abstract][Full Text] [Related]
23. Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers.
Strimaityte D; Tu C; Yanez A; Itzhaki I; Wu H; Wu JC; Yang H
ACS Appl Mater Interfaces; 2022 Aug; 14(31):35376-35388. PubMed ID: 35901275
[TBL] [Abstract][Full Text] [Related]
24. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy.
Knight WE; Cao Y; Lin YH; Chi C; Bai B; Sparagna GC; Zhao Y; Du Y; Londono P; Reisz JA; Brown BC; Taylor MRG; Ambardekar AV; Cleveland JC; McKinsey TA; Jeong MY; Walker LA; Woulfe KC; D'Alessandro A; Chatfield KC; Xu H; Bristow MR; Buttrick PM; Song K
Stem Cell Reports; 2021 Mar; 16(3):519-533. PubMed ID: 33636116
[TBL] [Abstract][Full Text] [Related]
25. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
[TBL] [Abstract][Full Text] [Related]
26. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
27. Video-based assessment of drug-induced effects on contractile motion properties using human induced pluripotent stem cell-derived cardiomyocytes.
Okai Y; Matsune K; Yamanaka K; Matsui T; Pfeiffer Kaushik E; Harada K; Kohara H; Miyawaki A; Ozaki H; Wagoner M; Shinozawa T
J Pharmacol Toxicol Methods; 2020 Sep; 105():106893. PubMed ID: 32619502
[TBL] [Abstract][Full Text] [Related]
28. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
29. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Wang L; Wada Y; Ballan N; Schmeckpeper J; Huang J; Rau CD; Wang Y; Gepstein L; Knollmann BC
J Mol Cell Cardiol; 2021 Dec; 161():130-138. PubMed ID: 34400182
[TBL] [Abstract][Full Text] [Related]
30. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.
Jung G; Fajardo G; Ribeiro AJ; Kooiker KB; Coronado M; Zhao M; Hu DQ; Reddy S; Kodo K; Sriram K; Insel PA; Wu JC; Pruitt BL; Bernstein D
FASEB J; 2016 Apr; 30(4):1464-79. PubMed ID: 26675706
[TBL] [Abstract][Full Text] [Related]
31. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
[TBL] [Abstract][Full Text] [Related]
32. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
33. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
[TBL] [Abstract][Full Text] [Related]
34. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
[TBL] [Abstract][Full Text] [Related]
35. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
[TBL] [Abstract][Full Text] [Related]
36. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
[TBL] [Abstract][Full Text] [Related]
37. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.
Zhang J; Klos M; Wilson GF; Herman AM; Lian X; Raval KK; Barron MR; Hou L; Soerens AG; Yu J; Palecek SP; Lyons GE; Thomson JA; Herron TJ; Jalife J; Kamp TJ
Circ Res; 2012 Oct; 111(9):1125-36. PubMed ID: 22912385
[TBL] [Abstract][Full Text] [Related]
38. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
39. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
[TBL] [Abstract][Full Text] [Related]
40. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.
Yang X; Rodriguez M; Pabon L; Fischer KA; Reinecke H; Regnier M; Sniadecki NJ; Ruohola-Baker H; Murry CE
J Mol Cell Cardiol; 2014 Jul; 72():296-304. PubMed ID: 24735830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
